Concepedia

Andrew G. Polson

AG

Statistics

Publications

48

Citations

4.1K

H-Index

33

Active since

1987

Affiliations

WuXi AppTec (China)(Current)

Genesys (United States)

Gene Therapy Laboratory

Amgen (United States)

Leeds Teaching Hospitals NHS Trust

Andrew G. Polson is an author at WuXi AppTec (China) specializing in antibody-drug conjugates, antibody-drug conjugate therapy, and oncology.

Publications per year

1987–2023

48

Publications

48

A whole-mount immunocytochemical analysis of the expression of the intermediate filament protein vimentin in <i>Xenopus</i>

Joseph A. Dent, Andrew G. Polson, Michael W. Klymkowsky · Development · 1989 · 451 citations

Life Sciences, Cell Biology, Molecular Biology +12

Therapeutic potential of an anti-CD79b antibody–drug conjugate, anti–CD79b-vc-MMAE, for the treatment of non-Hodgkin lymphoma

David Dornan, Fiona Bennett, Yvonne Chen et al. · Blood · 2009 · 271 citations · Full text

Pharmacy, Oncology, Pharmacology +17

Antibody-Drug Conjugates for the Treatment of Non–Hodgkin's Lymphoma: Target and Linker-Drug Selection

Andrew G. Polson, Jill Calemine-Fenaux, Pamela Chan et al. · Cancer Research · 2009 · 249 citations

Medicine, Oncology, Pharmacology +17

Targeting LGR5 <sup>+</sup> cells with an antibody-drug conjugate for the treatment of colon cancer

Melissa R. Junttila, Weiguang Mao, Xi Wang et al. · Science Translational Medicine · 2015 · 186 citations

Medicine, Cancer Biology, Oncology +14

Antibody-drug conjugates targeted to CD79 for the treatment of non-Hodgkin lymphoma

Andrew G. Polson, Shang‐Fan Yu, Kristi Elkins et al. · Blood · 2007 · 172 citations · Full text

Pharmacy, Medicinal Chemistry, Oncology +14

1–5 of 48